Effect of febuxostat on clinical outcomes in patients with hyperuricemia and cardiovascular disease-Reference-Cited by-同舟云学术

Effect of febuxostat on clinical outcomes in patients with hyperuricemia and cardiovascular disease

Published:2022-02 Issue: Volume:349 Page:127-133
ISSN:0167-5273
Container-title:International Journal of Cardiology
language:en
Short-container-title:International Journal of Cardiology

Author:

Konishi Masaaki,Kojima Sunao,Uchiyama Kazuaki,Yokota Naoto,Tokutake Eiichi,Wakasa Yutaka,Hiramitsu Shinya,Waki Masako,Jinnouchi Hideaki,Kakuda Hirokazu,Hayashi Takahiro,Kawai Naoki,Sugawara Masahiro,Mori Hisao,Tsujita Kenichi,Matsui Kunihiko,Hisatome Ichiro,Ohya Yusuke,Kimura Kazuo,Saito Yoshihiko,Ogawa Hisao

Funder

Teijin Pharma Limited

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference23 articles.

1. Prevalence and correlates of hyperuricemia in the middle-aged and older adults in China;Song;Sci. Rep.,2018

2. Contemporary prevalence of gout and hyperuricemia in the United States and decadal trends: the National Health and nutrition examination survey, 2007–2016;Chen-Xu;Arthritis Rheumatol,2019

3. Hyperuricemia has increased the risk of progression of chronic kidney disease: propensity score matching analysis from the KNOW-CKD study;Oh;Sci. Rep.,2019

4. Hyperuricemia and the risk for coronary heart disease morbidity and mortality a systematic review and dose-response meta-analysis;Li;Sci. Rep.,2016

5. Selectivity of febuxostat, a novel non-purine inhibitor of xanthine oxidase/xanthine dehydrogenase;Takano;Life Sci.,2005

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Amelioration of hyperuricemia by cordycepin and Cordyceps militaris aqueous extract in mice via modulating gut microbiota and restoring metabolic profile;Journal of Pharmaceutical and Biomedical Analysis;2024-10

2. Identification of a novel xanthine oxidoreductase inhibitor for hyperuricemia treatment with high efficacy and safety profile;Biomedicine & Pharmacotherapy;2024-09

3. Efficacy and safety of the urate-lowering agent febuxostat in chronic heart failure patients with hyperuricemia: results from the LEAF-CHF study;Heart and Vessels;2024-08-19

4. Exploration of leech therapy in treating gouty rats and its uric acid lowering mechanism;Journal of Ayurveda and Integrative Medicine;2024-07

5. Lacticaseibacillus paracasei JS-3 Isolated from “Jiangshui” Ameliorates Hyperuricemia by Regulating Gut Microbiota and iTS Metabolism;Foods;2024-04-29